Maternal Depression Treatment in HIV

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

391

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

August 31, 2023

Study Completion Date

May 31, 2024

Conditions
Depression
Interventions
COMBINATION_PRODUCT

evidence-based depression treatment

We will use a stepped care approach to depression treatment. Participants with clinical depression (defined as PHQ-9\>9) will be offered either Problem Solving Therapy (PST) or Antidepressant Therapy (ADT), but those with moderate to moderately severe depression will be recommended PST, while those with severe depression will be recommended ADT. Participants with subthreshold depressive symptoms (PHQ-9: 5-9) will receive depression psychoeducation and continued depressive monitoring.

Trial Locations (1)

Unknown

Makerere University, Kampala

All Listed Sponsors
collaborator

Makerere University

OTHER

collaborator

Mildmay Uganda Limited

OTHER

lead

RAND

OTHER

NCT03892915 - Maternal Depression Treatment in HIV | Biotech Hunter | Biotech Hunter